Cane Capital Partners’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.05M Sell
13,968
-4,288
-23% -$777K 0.81% 29
2026
Q1
$2.69M Buy
18,256
+10,995
+151% +$1.79M 1.17% 23
2025
Q4
$1.42M Buy
+7,261
New +$1.73M 0.56% 36

Other funds holding ORCL

Cane Capital Partners's ORCL Position: Q2 2026 in Review

Cane Capital Partners reduced its Oracle (ORCL) stake by 23% in Q2 2026, selling an estimated $777K and leaving 13,968 shares worth $2.05M. The position accounts for 0.81% of the portfolio, ranked #29.

Cane Capital Partners first reported a position in ORCL in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.69M in Q1 2026. 3,499 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • Cane Capital Partners held 13,968 shares of Oracle worth $2.05M as of Q2 2026.
  • Cane Capital Partners sold 4,288 Oracle shares in Q2 2026, an estimated $777K.
  • Oracle made up 0.81% of Cane Capital Partners's portfolio in Q2 2026, its #29 holding.
  • Cane Capital Partners first reported a position in Oracle in Q4 2025 and has held it in 3 quarters since.
  • Cane Capital Partners's Oracle position peaked at $2.69M in Q1 2026.
  • 3,499 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Cane Capital Partners's 13F filing for Q2 2026, filed 5 Aug 2026.